{"id":"W1539780911","doi":"10.1007/s10637-006-9022-7","title":"A phase II study of ZD6474 (Zactima™), a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma—NCIC CTG IND.145","year":2006,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Adverse effect; Rash; Internal medicine; Multiple myeloma; Nausea; Vomiting; Clinical endpoint; Anemia; Gastroenterology; Phases of clinical research; Diarrhea; Pharmacokinetics; Pharmacology; Clinical trial; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000148533,0.0002419682,0.0004628978,0.0003855468,0.00009187735,0.00001058653,0.0000745528,0.00008273699,0.00002176674],"category_scores_gemma":[0.0003492168,0.0001981988,0.00004203253,0.0006943088,0.0002549299,0.000194792,0.00006794954,0.0002265559,0.00000312991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000172027,"about_ca_system_score_gemma":0.0005599082,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003132695,"about_ca_topic_score_gemma":0.0004408177,"domain_scores_codex":[0.9978259,0.000098497,0.0005316942,0.0003969348,0.0008563783,0.0002905873],"domain_scores_gemma":[0.9986377,0.0002099187,0.0002526235,0.0002274461,0.0003835174,0.0002887688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005150647,0.01277642,0.9682695,0.00009807378,0.0001821937,0.00003989549,0.002524925,0.00005629569,0.007539871,0.00008134556,0.0004747377,0.00280609],"study_design_scores_gemma":[0.07189522,0.008838983,0.899248,0.0002726273,0.00008096333,0.00000444276,0.0002607942,0.0004493442,0.01839858,0.0003631808,0.00003055421,0.0001573014],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977262,0.00009997521,0.000007114664,0.0002399181,0.00002368517,0.001631867,0.0000849953,0.00002200447,0.000164266],"genre_scores_gemma":[0.9973778,0.00000183546,0.001864262,0.00004889603,0.00006511096,0.00007274972,0.0002973583,0.00002983476,0.0002422132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06902149,"threshold_uncertainty_score":0.8082312,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01286201718875107,"score_gpt":0.2673898610740773,"score_spread":0.2545278438853262,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}